In 2005, Yoneda et al. measured tau protein concentrations in the vitreous fluid from patients with different ocular diseases, finding a significant increase in the tau level in patients with glaucoma compared with the control macular-hole patients [51]. This evidence concerns the gene MAPT and glaucoma.